{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:54:44Z","timestamp":1787630084765,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF 024379"],"award-info":[{"award-number":["MJFF 024379"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Center for Advancing Translational Sciences of the National Institutes of Health","award":["KL2TR002367"],"award-info":[{"award-number":["KL2TR002367"]}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH2010656 - PD190057"],"award-info":[{"award-number":["W81XWH2010656 - PD190057"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Barrow Neurological Foundation, the Moreno Family, and the Kemper and Ethel Marley Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inj. Epidemiol."],"DOI":"10.1186\/s40621-025-00643-4","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:31:59Z","timestamp":1768231919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Excess risk of fracture in incident Parkinson\u2019s disease Medicare beneficiaries"],"prefix":"10.1186","volume":"13","author":[{"given":"Alejandra","family":"Camacho-Soto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Krzyzanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Killion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassu M.","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Ellerbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Sosnoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad A.","family":"Racette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"3","key":"643_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000275491","volume":"34","author":"A Wright Willis","year":"2010","unstructured":"Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143\u201351. https:\/\/doi.org\/10.1159\/000275491.","journal-title":"Neuroepidemiology"},{"issue":"6","key":"643_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/jnnp.72.6.721","volume":"72","author":"BH Wood","year":"2002","unstructured":"Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson\u2019s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002;72(6):721\u20135. https:\/\/doi.org\/10.1136\/jnnp.72.6.721.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"643_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1532-5415.2000.tb06884.x","volume":"48","author":"EW Gregg","year":"2000","unstructured":"Gregg EW, Pereira MA, Caspersen CJ. Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence. J Am Geriatr Soc. 2000;48(8):883\u201393. https:\/\/doi.org\/10.1111\/j.1532-5415.2000.tb06884.x.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"643_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094379","volume":"9","author":"L Tan","year":"2014","unstructured":"Tan L, Wang Y, Zhou L, Shi Y, Zhang F, Liu L, et al. Parkinson\u2019s disease and risk of fracture: a meta-analysis of prospective cohort studies. PLoS ONE. 2014;9(4):e94379. https:\/\/doi.org\/10.1371\/journal.pone.0094379.","journal-title":"PLoS ONE"},{"issue":"5","key":"643_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ana.25074","volume":"82","author":"A Camacho-Soto","year":"2017","unstructured":"Camacho-Soto A, Warden MN, Searles Nielsen S, Salter A, Brody DL, Prather H, et al. Traumatic brain injury in the prodromal period of Parkinson\u2019s disease: a large epidemiological study using medicare data. Ann Neurol. 2017;82(5):744\u201354. https:\/\/doi.org\/10.1002\/ana.25074.","journal-title":"Ann Neurol"},{"issue":"23","key":"643_CR6","doi-asserted-by":"publisher","first-page":"e2448","DOI":"10.1212\/WNL.0000000000009452","volume":"94","author":"A Camacho-Soto","year":"2020","unstructured":"Camacho-Soto A, Gross A, Searles Nielsen S, Miller AN, Warden MN, Salter A, et al. Fractures in the prodromal period of Parkinson disease. Neurology. 2020;94(23):e2448\u201356. https:\/\/doi.org\/10.1212\/WNL.0000000000009452.","journal-title":"Neurology"},{"issue":"5","key":"643_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jamda.2018.08.014","volume":"20","author":"SB Park","year":"2019","unstructured":"Park SB, Chung CK, Lee JY, Kim J. Risk factors for vertebral, hip, and femoral fractures among patients with Parkinson\u2019s disease: a 5-year follow-up in Korea. J Am Med Dir Assoc. 2019;20(5):617\u201323. https:\/\/doi.org\/10.1016\/j.jamda.2018.08.014.","journal-title":"J Am Med Dir Assoc"},{"key":"643_CR8","doi-asserted-by":"publisher","unstructured":"Pringsheim T, Day GS, Smith DB, Rae-Grant A, Licking N, Armstrong MJ, de Bie RMA, Roze E, Miyasaki JM, Hauser RA, Espay AJ, Martello JP, Gurwell JA, Billinghurst L, Sullivan K, Fitts MS, Cothros N, Hall DA, Rafferty M, Hagerbrant L, Hastings T, O\u2019Brien MD, Silsbee H, Gronseth G, Lang AE, AAN GSot. Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology. 2021;97(20):942\u201357. https:\/\/doi.org\/10.1212\/WNL.0000000000012868. PubMed PMID: 34782410; PMCID: PMC8672433.","DOI":"10.1212\/WNL.0000000000012868"},{"issue":"10","key":"643_CR9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/jnnp-2013-307307","volume":"85","author":"KM Torsney","year":"2014","unstructured":"Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ. Bone health in Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85(10):1159\u201366. https:\/\/doi.org\/10.1136\/jnnp-2013-307307.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"643_CR10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00198-015-3052-y","volume":"26","author":"YF Huang","year":"2015","unstructured":"Huang YF, Cherng YG, Hsu SP, Yeh CC, Chou YC, Wu CH, et al. Risk and adverse outcomes of fractures in patients with Parkinson\u2019s disease: two nationwide studies. Osteoporos Int. 2015;26(6):1723\u201332. https:\/\/doi.org\/10.1007\/s00198-015-3052-y.","journal-title":"Osteoporos Int"},{"issue":"9","key":"643_CR11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.20946","volume":"21","author":"LJ Melton","year":"2006","unstructured":"Melton LJ, Leibson CL, Achenbach SJ, Bower JH, Maraganore DM, Oberg AL, et al. Fracture risk after the diagnosis of Parkinson\u2019s disease: influence of concomitant dementia. Mov Disord. 2006;21(9):1361\u20137. https:\/\/doi.org\/10.1002\/mds.20946.","journal-title":"Mov Disord"},{"issue":"1","key":"643_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/ageing\/afh203","volume":"34","author":"RW Genever","year":"2005","unstructured":"Genever RW, Downes TW, Medcalf P. Fracture rates in Parkinson\u2019s disease compared with age- and gender-matched controls: a retrospective cohort study. Age Ageing. 2005;34(1):21\u20134. https:\/\/doi.org\/10.1093\/ageing\/afh203.","journal-title":"Age Ageing"},{"key":"643_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2016.11.005","volume":"35","author":"HA Beydoun","year":"2017","unstructured":"Beydoun HA, Beydoun MA, Mishra NK, Rostant OS, Zonderman AB, Eid SM. Comorbid Parkinson\u2019s disease, falls and fractures in the 2010 National Emergency Department Sample. Parkinsonism Relat Disord. 2017;35:30\u20135. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.11.005.","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"643_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161689","volume":"11","author":"L Kalilani","year":"2016","unstructured":"Kalilani L, Asgharnejad M, Palokangas T, Durgin T. Comparing the incidence of falls\/fractures in Parkinson\u2019s disease patients in the US population. PLoS One. 2016;11(9):e0161689. https:\/\/doi.org\/10.1371\/journal.pone.0161689.","journal-title":"PLoS One"},{"issue":"4","key":"643_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.15441\/ceem.17.261","volume":"5","author":"SB Lee","year":"2018","unstructured":"Lee SB, Oh JH, Park JH, Choi SP, Wee JH. Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department. Clin Exp Emerg Med. 2018;5(4):249\u201355. https:\/\/doi.org\/10.15441\/ceem.17.261.","journal-title":"Clin Exp Emerg Med"},{"issue":"24","key":"643_CR16","doi-asserted-by":"publisher","first-page":"e2155","DOI":"10.1212\/WNL.0000000000005678","volume":"90","author":"A Gross","year":"2018","unstructured":"Gross A, Racette BA, Camacho-Soto A, Dube U, Searles Nielsen S. Use of medical care biases associations between Parkinson disease and other medical conditions. Neurology. 2018;90(24):e2155\u201365. https:\/\/doi.org\/10.1212\/WNL.0000000000005678.","journal-title":"Neurology"},{"key":"643_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2018.02.008","volume":"50","author":"A Camacho-Soto","year":"2018","unstructured":"Camacho-Soto A, Gross A, Searles Nielsen S, Dey N, Racette BA. Inflammatory bowel disease and risk of Parkinson\u2019s disease in Medicare beneficiaries. Parkinsonism Relat Disord. 2018;50:23\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.008.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"643_CR18","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/acn3.580","volume":"5","author":"BA Racette","year":"2018","unstructured":"Racette BA, Gross A, Vouri SM, Camacho-Soto A, Willis AW, Searles Nielsen S. Immunosuppressants and risk of Parkinson disease. Ann Clin Transl Neurol. 2018;5(7):870\u20135. https:\/\/doi.org\/10.1002\/acn3.580.","journal-title":"Ann Clin Transl Neurol"},{"issue":"26","key":"643_CR19","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible - The Neighborhood Atlas. N Engl J Med. 2018;378(26):2456\u20138. https:\/\/doi.org\/10.1056\/NEJMp1802313.","journal-title":"N Engl J Med"},{"key":"643_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2023.04.019","author":"I Faust","year":"2023","unstructured":"Faust I, Warden M, Camacho-Soto A, Racette BA, Searles Nielsen S. A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies. Ann Epidemiol. 2023. https:\/\/doi.org\/10.1016\/j.annepidem.2023.04.019.","journal-title":"Ann Epidemiol"},{"issue":"8","key":"643_CR21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214174","volume":"105","author":"B Krzyzanowski","year":"2025","unstructured":"Krzyzanowski B, Beyene KM, Turner JR, Racette BA. Ambient trichloroethylene exposure and Parkinson disease risk in Medicare beneficiaries. Neurology. 2025;105(8):e214174. https:\/\/doi.org\/10.1212\/WNL.0000000000214174.","journal-title":"Neurology"},{"issue":"7","key":"643_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/gerona\/glx229","volume":"73","author":"DH Kim","year":"2018","unstructured":"Kim DH, Schneeweiss S, Glynn RJ, Lipsitz LA, Rockwood K, Avorn J. Measuring frailty in Medicare data: development and validation of a claims-based frailty index. J Gerontol A Biol Sci Med Sci. 2018;73(7):980\u20137. https:\/\/doi.org\/10.1093\/gerona\/glx229.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"643_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/2151458510378105","volume":"1","author":"S Schnell","year":"2010","unstructured":"Schnell S, Friedman SM, Mendelson DA, Bingham KW, Kates SL. The 1-year mortality of patients treated in a hip fracture program for elders. Geriatr Orthop Surg Rehabil. 2010;1(1):6\u201314. https:\/\/doi.org\/10.1177\/2151458510378105.","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"1","key":"643_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000339626","volume":"36","author":"JB Wetmore","year":"2012","unstructured":"Wetmore JB, Mahnken JD, Rigler SK, Ellerbeck EF, Mukhopadhyay P, Hou Q, et al. Association of race with cumulative exposure to statins in dialysis. Am J Nephrol. 2012;36(1):90\u20136. https:\/\/doi.org\/10.1159\/000339626.","journal-title":"Am J Nephrol"},{"issue":"9","key":"643_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.18553\/jmcp.2009.15.9.728","volume":"15","author":"J Yeaw","year":"2009","unstructured":"Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15(9):728\u201340. https:\/\/doi.org\/10.18553\/jmcp.2009.15.9.728.","journal-title":"J Manag Care Pharm"},{"key":"643_CR26","doi-asserted-by":"publisher","unstructured":"Jost ST, Kaldenbach MA, Antonini A, Martinez-Martin P, Timmermann L, Odin P, Katzenschlager R, Borgohain R, Fasano A, Stocchi F, Hattori N, Kukkle PL, Rodr\u00edguez-Violante M, Falup-Pecurariu C, Schade S, Petry-Schmelzer JN, Metta V, Weintraub D, Deuschl G, Espay AJ, Tan EK, Bhidayasiri R, Fung VSC, Cardoso F, Trenkwalder C, Jenner P, Ray Chaudhuri K, Dafsari HS, Group IPaMDSN-MPDS. Levodopa Dose Equivalency in Parkinson\u2019s Disease: Updated Systematic Review and Proposals. Mov Disord. 2023;38(7):1236\u201352. Epub 20230505. https:\/\/doi.org\/10.1002\/mds.29410. PubMed PMID: 37147135.","DOI":"10.1002\/mds.29410"},{"issue":"1","key":"643_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.apmr.2017.07.011","volume":"99","author":"JK Freburger","year":"2018","unstructured":"Freburger JK, Li D, Fraher EP. Community use of physical and occupational therapy after stroke and risk of hospital readmission. Arch Phys Med Rehabil. 2018;99(1):26-34.e5. https:\/\/doi.org\/10.1016\/j.apmr.2017.07.011.","journal-title":"Arch Phys Med Rehabil"},{"issue":"11","key":"643_CR28","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/pds.5662","volume":"32","author":"TG Horton","year":"2023","unstructured":"Horton TG, Richardson TL, Hackstadt AJ, Halvorson AE, Hung AM, Greevy R, et al. Validation of an algorithm to identify fractures among patients within the Veterans Health Administration. Pharmacoepidemiol Drug Saf. 2023;32(11):1290\u20138. https:\/\/doi.org\/10.1002\/pds.5662.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"643_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/ip.2005.009076","volume":"12","author":"LA Fingerhut","year":"2006","unstructured":"Fingerhut LA, Warner M. The ICD-10 injury mortality diagnosis matrix. Inj Prev. 2006;12(1):24\u20139. https:\/\/doi.org\/10.1136\/ip.2005.009076.","journal-title":"Inj Prev"},{"key":"643_CR30","unstructured":"StataCorp.Stata\/MP 18.0. College Station TSL, 2023."},{"issue":"446","key":"643_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2307\/2670170","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509. https:\/\/doi.org\/10.2307\/2670170.","journal-title":"J Am Stat Assoc"},{"key":"643_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jclinepi.2020.03.004","volume":"122","author":"NA Schuster","year":"2020","unstructured":"Schuster NA, Hoogendijk EO, Kok AAL, Twisk JWR, Heymans MW. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis. J Clin Epidemiol. 2020;122:42\u20138. https:\/\/doi.org\/10.1016\/j.jclinepi.2020.03.004.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"643_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001954","volume":"13","author":"H Nystr\u00f6m","year":"2016","unstructured":"Nystr\u00f6m H, Nordstr\u00f6m A, Nordstr\u00f6m P. Risk of injurious fall and hip fracture up to 26 y before the diagnosis of Parkinson disease: nested case-control studies in a nationwide cohort. PLoS Med. 2016;13(2):e1001954. https:\/\/doi.org\/10.1371\/journal.pmed.1001954.","journal-title":"PLoS Med"},{"issue":"9","key":"643_CR34","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00198-025-07632-9","volume":"36","author":"MTY Leung","year":"2025","unstructured":"Leung MTY, Lamidi ML, Hartikainen S, Rajamaki B, Bell JS, Turner JP, et al. Incidence of hip fractures in persons with and without Parkinson\u2019s disease in Finland: a 15-year longitudinal study. Osteoporos Int. 2025;36(9):1681\u201390. https:\/\/doi.org\/10.1007\/s00198-025-07632-9.","journal-title":"Osteoporos Int"},{"issue":"1","key":"643_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00198-022-06562-0","volume":"34","author":"HY Koo","year":"2023","unstructured":"Koo HY, Cho EB, Kong SH, Han K, Lee KN, Yoo JE, et al. Fracture risk in Parkinson\u2019s disease according to its severity and duration. Osteoporos Int. 2023;34(1):81\u20139. https:\/\/doi.org\/10.1007\/s00198-022-06562-0.","journal-title":"Osteoporos Int"},{"key":"643_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115173","volume":"132","author":"M Schini","year":"2020","unstructured":"Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, et al. The risk of hip and non-vertebral fractures in patients with Parkinson\u2019s disease and parkinsonism: a systematic review and meta-analysis. Bone. 2020;132:115173. https:\/\/doi.org\/10.1016\/j.bone.2019.115173.","journal-title":"Bone"},{"issue":"1","key":"643_CR37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.bone.2012.09.013","volume":"52","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Shen L, Ji HF. Osteoporosis risk and bone mineral density levels in patients with Parkinson\u2019s disease: a meta-analysis. Bone. 2013;52(1):498\u2013505. https:\/\/doi.org\/10.1016\/j.bone.2012.09.013.","journal-title":"Bone"},{"issue":"3","key":"643_CR38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jbmr.3074","volume":"32","author":"S Khosla","year":"2017","unstructured":"Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG, et al. Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res. 2017;32(3):424\u201330. https:\/\/doi.org\/10.1002\/jbmr.3074.","journal-title":"J Bone Miner Res"},{"key":"643_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf052","author":"KC Naylor","year":"2025","unstructured":"Naylor KC, Tenis On E, Hardcastle SA, Lyell V, Gregson CL, Henderson EJ. Assessing and managing bone health and fracture risk in Parkinson\u2019s disease: the BONE PARK 2 protocol. Age Ageing. 2025. https:\/\/doi.org\/10.1093\/ageing\/afaf052.","journal-title":"Age Ageing"},{"key":"643_CR40","doi-asserted-by":"publisher","unstructured":"Shepherd JA, Lu Y, Wilson K, Fuerst T, Genant H, Hangartner TN, Wilson C, Hans D, Leib ES, Measurement ISfCDCoSoB. Cross-calibration and minimum precision standards for dual-energy X-ray absorptiometry: the 2005 ISCD Official Positions. J Clin Densitom. 2006;9(1):31\u20136. Epub 20060512. https:\/\/doi.org\/10.1016\/j.jocd.2006.05.005. PubMed PMID: 16731429.","DOI":"10.1016\/j.jocd.2006.05.005"},{"issue":"12","key":"643_CR41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ncprheum0928","volume":"4","author":"EM Lewiecki","year":"2008","unstructured":"Lewiecki EM, Lane NE. Common mistakes in the clinical use of bone mineral density testing. Nat Clin Pract Rheumatol. 2008;4(12):667\u201374. https:\/\/doi.org\/10.1038\/ncprheum0928.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"643_CR42","doi-asserted-by":"publisher","unstructured":"Bolotin HH. Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral densitometry may flaw osteopenic\/osteoporotic interpretations and mislead assessment of antiresorptive therapy effectiveness. Bone. 2001;28(5):548-55. https:\/\/doi.org\/10.1016\/s8756-3282(01)00423-9. PubMed PMID: 11344055.","DOI":"10.1016\/s8756-3282(01)00423-9"},{"issue":"1","key":"643_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/jbmr.506","volume":"27","author":"EW Yu","year":"2012","unstructured":"Yu EW, Thomas BJ, Brown JK, Finkelstein JS. Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. J Bone Miner Res. 2012;27(1):119\u201324. https:\/\/doi.org\/10.1002\/jbmr.506.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"643_CR44","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00198-012-2221-5","volume":"24","author":"C Hansen","year":"2013","unstructured":"Hansen C, Pedersen BD, Konradsen H, Abrahamsen B. Anti-osteoporotic therapy in Denmark--predictors and demographics of poor refill compliance and poor persistence. Osteoporos Int. 2013;24(7):2079\u201397. https:\/\/doi.org\/10.1007\/s00198-012-2221-5.","journal-title":"Osteoporos Int"},{"issue":"1","key":"643_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00162-1","volume":"7","author":"CM Tanner","year":"2021","unstructured":"Tanner CM, Cummings SR, et al. The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. NPJ Parkinsons Dis. 2021;7(1):16. https:\/\/doi.org\/10.1038\/s41531-021-00162-1.","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"643_CR46","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.injury.2022.03.015","volume":"53","author":"PV Nguyen","year":"2022","unstructured":"Nguyen PV, Hjelholt TJ, Heide-J\u00f8rgensen U, Pedersen AB. Postoperative complications, mortality, and quality of in-hospital care among hip fracture patients with Parkinson\u2019s disease. Injury. 2022;53(6):2150\u20137. https:\/\/doi.org\/10.1016\/j.injury.2022.03.015.","journal-title":"Injury"},{"issue":"4","key":"643_CR47","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/jim-2018-000907","volume":"67","author":"RR Narla","year":"2019","unstructured":"Narla RR, Hirano LA, Lo SHY, Anawalt BD, Phelan EA, Matsumoto AM. Suboptimal osteoporosis evaluation and treatment in older men with and without additional high-risk factors for fractures. J Investig Med. 2019;67(4):743\u20139. https:\/\/doi.org\/10.1136\/jim-2018-000907.","journal-title":"J Investig Med"},{"key":"643_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac273","author":"SN Robinovitch","year":"2022","unstructured":"Robinovitch SN, Dojnov A, Komisar V, Yang Y, Shishov N, Yu Y, et al. Protective responses of older adults for avoiding injury during falls: evidence from video capture of real-life falls in long-term care. Age Ageing. 2022. https:\/\/doi.org\/10.1093\/ageing\/afac273.","journal-title":"Age Ageing"},{"issue":"10","key":"643_CR49","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1177\/1545968316648669","volume":"30","author":"DS Peterson","year":"2016","unstructured":"Peterson DS, Horak FB. The effect of Levodopa on improvements in protective stepping in people with Parkinson\u2019s disease. Neurorehabil Neural Repair. 2016;30(10):931\u201340. https:\/\/doi.org\/10.1177\/1545968316648669.","journal-title":"Neurorehabil Neural Repair"},{"issue":"9","key":"643_CR50","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/WNL.0b013e31822c9123","volume":"77","author":"AW Willis","year":"2011","unstructured":"Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology. 2011;77(9):851\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e31822c9123.","journal-title":"Neurology"},{"issue":"1","key":"643_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00523-y","volume":"9","author":"C Pearson","year":"2023","unstructured":"Pearson C, Hartzman A, Munevar D, Feeney M, Dolhun R, Todaro V, et al. Care access and utilization among medicare beneficiaries living with Parkinson\u2019s disease. NPJ Parkinsons Dis. 2023;9(1):108. https:\/\/doi.org\/10.1038\/s41531-023-00523-y.","journal-title":"NPJ Parkinsons Dis"},{"key":"643_CR52","doi-asserted-by":"publisher","unstructured":"Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA, Group LS. Randomized Delayed-Start Trial of Levodopa in Parkinson\u2019s Disease. N Engl J Med. 2019;380(4):315-24. https:\/\/doi.org\/10.1056\/NEJMoa1809983. PubMed PMID: 30673543.","DOI":"10.1056\/NEJMoa1809983"},{"key":"643_CR53","doi-asserted-by":"publisher","unstructured":"Frequin HL, Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Dijk JM, Lang AE, Dijkgraaf MGW, Hoogland J, de Bie RMA, Group LS. Long-Term Follow-Up of the LEAP Study: Early Versus Delayed Levodopa in Early Parkinson\u2019s Disease. Mov Disord. 2024;39(6):975-82. Epub 20240421. https:\/\/doi.org\/10.1002\/mds.29796. PubMed PMID: 38644623.","DOI":"10.1002\/mds.29796"},{"key":"643_CR54","doi-asserted-by":"publisher","unstructured":"Frequin HL, Schouten J, Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Dijk JM, Deuschl G, Lang A, Dijkgraaf MGW, de Haan RJ, de Bie RMA, Group LS. Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study. Neurology. 2023;100(4):e367-e76. Epub 20221017. https:\/\/doi.org\/10.1212\/WNL.0000000000201448. PubMed PMID: 36253105.","DOI":"10.1212\/WNL.0000000000201448"},{"issue":"3","key":"643_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00223-007-9065-6","volume":"81","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcif Tissue Int. 2007;81(3):153\u201361. https:\/\/doi.org\/10.1007\/s00223-007-9065-6.","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"643_CR56","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00198-010-1455-3","volume":"22","author":"ME Arbouw","year":"2011","unstructured":"Arbouw ME, Movig KL, van Staa TP, Egberts AC, Souverein PC, de Vries F. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporos Int. 2011;22(7):2197\u2013204. https:\/\/doi.org\/10.1007\/s00198-010-1455-3.","journal-title":"Osteoporos Int"},{"issue":"3","key":"643_CR57","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mds.23450","volume":"26","author":"L Rochester","year":"2011","unstructured":"Rochester L, Baker K, Nieuwboer A, Burn D. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson\u2019s disease: selective responses to internal and external cues. Mov Disord. 2011;26(3):430\u20135. https:\/\/doi.org\/10.1002\/mds.23450.","journal-title":"Mov Disord"},{"issue":"3","key":"643_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1136\/jnnp.73.3.267","volume":"73","author":"L Rocchi","year":"2002","unstructured":"Rocchi L, Chiari L, Horak FB. Effects of deep brain stimulation and levodopa on postural sway in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2002;73(3):267\u201374. https:\/\/doi.org\/10.1136\/jnnp.73.3.267.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"643_CR59","doi-asserted-by":"publisher","unstructured":"Beuter A, Hern\u00e1ndez R, Rigal R, Modolo J, Blanchet PJ. Postural sway and effect of levodopa in early Parkinson\u2019s disease. Can J Neurol Sci. 2008;35(1):65-8. https:\/\/doi.org\/10.1017\/s0317167100007575. PubMed PMID: 18380279.","DOI":"10.1017\/s0317167100007575"},{"issue":"2","key":"643_CR60","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0041-1725133","volume":"41","author":"TD Ellis","year":"2021","unstructured":"Ellis TD, Col\u00f3n-Semenza C, DeAngelis TR, Thomas CA, Hilaire MS, Earhart GM, et al. Evidence for early and regular physical therapy and exercise in Parkinson\u2019s disease. Semin Neurol. 2021;41(2):189\u2013205. https:\/\/doi.org\/10.1055\/s-0041-1725133.","journal-title":"Semin Neurol"},{"issue":"24","key":"643_CR61","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1212\/WNL.0000000000002768","volume":"86","author":"JF van der Heeden","year":"2016","unstructured":"van der Heeden JF, Marinus J, Martinez-Martin P, Rodriguez-Blazquez C, Geraedts VJ, van Hilten JJ. Postural instability and gait are associated with severity and prognosis of Parkinson disease. Neurology. 2016;86(24):2243\u201350. https:\/\/doi.org\/10.1212\/WNL.0000000000002768.","journal-title":"Neurology"},{"issue":"3","key":"643_CR62","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/mds.26110","volume":"30","author":"B Galna","year":"2015","unstructured":"Galna B, Lord S, Burn DJ, Rochester L. Progression of gait dysfunction in incident Parkinson\u2019s disease: impact of medication and phenotype. Mov Disord. 2015;30(3):359\u201367. https:\/\/doi.org\/10.1002\/mds.26110.","journal-title":"Mov Disord"},{"issue":"2","key":"643_CR63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00223-009-9327-6","volume":"86","author":"SH Lee","year":"2010","unstructured":"Lee SH, Kim MJ, Kim BJ, Kim SR, Chun S, Kim HK, et al. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson\u2019s disease. Calcif Tissue Int. 2010;86(2):132\u201341. https:\/\/doi.org\/10.1007\/s00223-009-9327-6.","journal-title":"Calcif Tissue Int"},{"key":"643_CR64","unstructured":"Tarazi W WP, Nguyen N, et al. Medicare Beneficiary Enrollment Trends and Demographic Characteristics. Vol. March 2022. 2022. Issue Brief No. HP-2022\u201308. March. Accessed September 26, 2023. https:\/\/aspe.hhs.gov\/sites\/default\/files\/documents\/f81aafbba0b331c71c6e8bc66512e25d\/medicare-beneficiary-enrollment-ib.pdf."},{"issue":"8","key":"643_CR65","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00198-013-2300-2","volume":"24","author":"S Pouwels","year":"2013","unstructured":"Pouwels S, Bazelier MT, de Boer A, Weber WE, Neef C, Cooper C, et al. Risk of fracture in patients with Parkinson\u2019s disease. Osteoporos Int. 2013;24(8):2283\u201390. https:\/\/doi.org\/10.1007\/s00198-013-2300-2.","journal-title":"Osteoporos Int"}],"container-title":["Injury Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40621-025-00643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40621-025-00643-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40621-025-00643-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:21:17Z","timestamp":1768342877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40621-025-00643-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1186\/s40621-025-00643-4","relation":{},"ISSN":["2197-1714"],"issn-type":[{"value":"2197-1714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was deemed exempt by Barrow Neurological Institute (PHX-23\u2013500-322\u201311-49) and the Centers for Medicare and Medicaid Services (CMS) (Data use agreement 27506).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}